Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/23209
Appears in Collections:Biological and Environmental Sciences Journal Articles
Title: Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease
Authors: Hill, Rebecca M
Kuijper, Sanne
Lindsey, Janet C
Petrie, Kevin
Schwalbe, Ed C
Barker, Karen
Boult, Jessica K R
Williamson, Daniel
Ahmad, Zai
Hallsworth, Albert
Ryan, Sarra L
Poon, Evon
Robinson, Simon P
Ruddle, Ruth
Raynaud, Florence I
Contact Email: kevin.petrie@stir.ac.uk
Issue Date: 12-Jan-2015
Publisher: Elsevier
Citation: Hill RM, Kuijper S, Lindsey JC, Petrie K, Schwalbe EC, Barker K, Boult JKR, Williamson D, Ahmad Z, Hallsworth A, Ryan SL, Poon E, Robinson SP, Ruddle R & Raynaud FI (2015) Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease, Cancer Cell, 27 (1), pp. 72-84.
Abstract: We undertook a comprehensive clinical and biological investigation of serial medulloblastoma biopsies obtained at diagnosis and relapse. CombinedMYCfamily amplifications and P53 pathway defects commonly emerged at relapse, and all patients in this group died of rapidly progressive disease postrelapse. To study this interaction, we investigated a transgenic model of MYCN-driven medulloblastoma and found spontaneous development ofTrp53inactivating mutations. Abrogation of p53 function in this model produced aggressive tumors that mimicked characteristics of relapsed human tumors with combined P53-MYC dysfunction. Restoration of p53 activity and genetic and therapeutic suppression of MYCN all reduced tumor growth and prolonged survival. Our findings identify P53-MYC interactions at medulloblastoma relapse as biomarkers of clinically aggressive disease that may be targeted therapeutically.
Type: Journal Article
URI: http://hdl.handle.net/1893/23209
DOI Link: http://dx.doi.org/10.1016/j.ccell.2014.11.002
Rights: This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
Notes: Additional co-authors: Louise Howell, Colin Kwok, Abhijit Joshi, Sarah Leigh Nicholson, Stephen Crosier, David W. Ellison, Stephen B. Wharton, Keith Robson, Antony Michalski, Darren Hargrave, Thomas S. Jacques, Barry Pizer, Simon Bailey, Fredrik J. Swartling, William A. Weiss, Louis Chesler, Steven C. Clifford
Affiliation: Newcastle University
Institute of Cancer Research
Newcastle University
Biological and Environmental Sciences
Newcastle University
Institute of Cancer Research
Institute of Cancer Research
Newcastle University
Institute of Cancer Research
Institute of Cancer Research
Newcastle University
Institute of Cancer Research
Institute of Cancer Research
Institute of Cancer Research
Institute of Cancer Research

Files in This Item:
File Description SizeFormat 
Hill et al_Cancer Cell_2015.pdf6.57 MBAdobe PDFView/Open


This item is protected by original copyright



Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.